Radial is advancing its post-traumatic stress disorder treatment offering through the integration of Prism neurofeedback technology from GrayMatters Health, aiming to help patients regulate brain activity without verbally revisiting traumatic events. This non-pharmacological, simulation-based approach is designed to broaden access for individuals reluctant to engage in traditional talk therapy.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company is also highlighting Prism Imagine, a new mobile-enabled feature that visually represents a patient’s mental strategies and can be shared with clinicians or family members. Radial’s CMO, Dr. Owen Scott Muir, indicated that these visual tools may make complex neurofeedback care more understandable, potentially boosting patient engagement and differentiating the company’s behavioral health services.
By aligning with evidence-backed digital therapeutics and neurotechnology, Radial is positioning itself at the intersection of behavioral health and innovative tech-enabled care. The model relies on ecosystem partnerships rather than fully proprietary platforms, which reduces development risk but increases dependence on third-party innovation and licensing terms.
Commercial impact will depend on clinical validation, payer reimbursement pathways, and Radial’s success in turning these tools into scalable, recurring revenue. Overall, this week’s developments underscore Radial’s strategic commitment to advanced neurofeedback solutions for PTSD, reinforcing its competitive stance as demand for innovative mental health treatments continues to grow.